Oaktree Specialty Lending Corporation (OCSL) Earnings Call Transcript
May 5, 2026
Earnings Call Speaker Segments
Thanks, operator. This morning we put out our earnings release for the second quarter of 2026, and you can find it, together with the slide presentation that goes with it, in the Investors section of our site, oaktreespecialtylending.com. Before we get going, I should note that what we say on today's call contains forward-looking statements that reflect our present views about, among other things, how we'll operate and perform financially down the road. What actually happens may differ materially from what those forward-looking statements imply or express. For a fuller discussion of these factors, please look at the relevant SEC filings. Oaktree has no obligation to update or revise any forward-looking statements. I also want to note that nothing said on this call is an offer to sell or a solicitation of an offer to buy any interest in an Oaktree fund. Investors and others should know that OCSL announces material information through the Investors section of its corporate website. The company urges investors, the media and others to review what it posts on its website; with that, I'll hand things over to Matt Pendo, President of OCSL. Matt?
Thanks, Alison, and good morning to all of you. I'll start by walking through our results for the second quarter of fiscal 2026, and after that Armen Panossian, our CEO and Co-Chief Investment Officer, will offer his take on where the market stands. Then Raghav Khanna, our Co-Chief Investment Officer, will discuss portfolio activity, and Chris McKown, our CFO and Treasurer, will wrap up with a look at our financial results before we take questions. Even with all the outside chatter about private credit and BDCs, our team stayed dialed in on bringing nonaccruals down and getting our balance sheet into a flexible position. At March 31, 2026, nonaccruals represented 2.6% of the total debt portfolio at fair value, which is lower than the 3.1% we saw last quarter and the 4.6% recorded 1 year ago. As a post-quarter update, during April we divested 2 legacy nonaccrual positions, Dominion Diagnostics and All Web Leads. Over the months ahead, we anticipate making additional headway on lowering nonaccruals and generating cash proceeds that we can put to work in performing assets. A key priority for us is managing the balance sheet as we get OCSL ready for a more appealing investment backdrop. In the quarter, we divested part of our liquid credit positions at cost, a deliberate move to build dry powder, keep leverage under the midpoint of our target range and rotate away from lower-yielding public credit. We closed the second quarter with $671 million of available liquidity, which is $100 million higher than last quarter, and net leverage of 1.04x, versus 1.07x last quarter. Now on to financial highlights. Net asset value per share came to $15.69 at March 31, 2026, versus $16.30 at December 31, 2025. That drop was mainly the result of unrealized mark-to-market write-downs on software loans during the quarter. The fair value of our performing software loans fell by roughly 310 basis points, which is largely in line with what happened in broadly syndicated software loans. The important point is that we don't view these markdowns as generally signaling weakening fundamentals at the underlying portfolio companies; instead, they reflect how risk is being repriced across the broader markets. Adjusted net investment income for the quarter totaled $33.7 million, or $0.38 per share, compared with $36.1 million, or $0.41 per share, in the prior quarter. That decrease came from lower reference rates, reduced nonrecurring income and ending leverage below the midpoint of our target range; for the quarter, our Board declared a total cash dividend of $0.34 per share. Given our conservative use of leverage, we have reset our base dividend to $0.30 per share while keeping our supplemental dividend at 50% of excess adjusted net investment income above our base dividend. These dividends are payable on June 30, 2026, to stockholders of record as of June 15, 2026. With that, I'll hand the call over to Armen to share his view of the market environment and what lies ahead.
Thanks, Matt. Private credit had quite a busy quarter. In our view, the swings we're witnessing point to a stretch of readjustment, not something systemic. A number of topics are swirling around private credit right now: impairments on the rise, uncertainty about valuations, how leverage gets used, mismatches in liquidity, exposure to software as AI reshapes things, and refinancing dangers. That could shed some light — partly, anyway — on why the mood in the market looks worse than what borrower results on their own would imply, since all these worries together drag down investor confidence. Today's argument about private credit hazards might blend together several separate issues, producing conclusions that are too sweeping; one has to separate the sound core idea behind private credit — customized lending outside the banks — from the particular problems hitting certain corners of the market. There's nothing inherently wrong with direct lending, or extending private loans to fund buyouts of midsized companies. What every manager must ask is whether their portfolio's assets and liabilities were structured to withstand a market downturn. Here at Oaktree, we bring over 30 years of experience putting money to work in sub-investment-grade credit and steering through market cycles. We've seen this kind of moment before. Take 2020: OCSL's positioning came about because of intentional decisions made long before the COVID-driven dislocation hit. By late 2019, we'd already cleared out the legacy portfolio inherited from the previous adviser, brought leverage down, and strengthened liquidity in the fund. Once dislocation struck in March 2020, we held the dry powder and the conviction to play offense. During 2020, we put close to $1 billion of capital to work and delivered close to an 11% total economic return in a year when plenty of managers pulled back. Right now, OCSL is operating with that same mindset. Progress continues on rehabilitating underperforming assets, we're running below the midpoint of our leverage target, staying disciplined about deployment, and keeping liquidity strong. We didn't foresee the environment we're in today, but we're ready to put money to work in it. Volatility picked up this quarter, and worries tied to AI along with geopolitical turmoil pushed spreads wider throughout public liquid credit markets. Meanwhile, heavy net redemptions at nontraded BDCs led many managers to rethink their cost of capital and their liquidity standing, which moved private credit into a stretch of price discovery. As the quarter neared its end, market conditions settled down and the pipeline of private credit deals started to refill. We take encouragement from the fact that spreads on fresh private credit investments have widened to SOFR plus 500 to 550 basis points, roughly 50 to 100 basis points wider than the 2025 tights, which supports better returns going forward. We're likewise observing slight gains in documentation and structures that favor lenders more. Even though markets have climbed back off their lows, we anticipate ongoing volatility and growing dispersion in the quarters ahead. In our opinion, secondary trades in the private realm — whether they involve selling part of a portfolio or the whole thing — are going to transform the private credit sector, since some players in the market are seeking to fine-tune their asset mix or meet needs for liquidity; Oaktree, we think, is positioned favorably to assess and possibly take advantage of every one of these chances. Having a platform that spans the globe represents a substantial edge under these conditions; we look at private credit side by side with liquid credit, distressed debt, asset-backed finance and — more and more — the Brookfield ecosystem. That capacity to weigh relative value across credit and, at this point, equity shapes both how we manage risk and how we deploy capital in a manner that a manager focused on a single strategy simply cannot match. Working together, we are going to possess a completely connected information network spanning asset classes, industries, geographies and both public and private markets. Already, we are monitoring dozens of opportunities that are emerging, doing so in real time, exchanging observations among teams and spotting dislocations. The scope of our joint ties to sponsors, companies and advisers is going to provide us with access to deal flow that a large number of lenders never encounter and lets us stay selective. Underwriting with discipline, being selective and managing the portfolio actively are going to stay the essential forces behind long-term performance. At this point I will hand the call to Raghav, so he can give a thorough review of our portfolio and investment activity.
Thanks, Armen. As both Matt and Armen noted, our investment activity during the second quarter was restrained, since we remained focused on risk control and keeping the balance sheet flexible. In that quarter, we disposed of some liquid credit positions at cost in order to accumulate dry powder. In addition, we observed a solid rate of prepayments across the private portfolio. Cash generated from prepayments, exits, other paydowns, and sales came to $334 million, compared with $179 million in the prior quarter and $279 million a year earlier. One prepayment worth highlighting was Mindbody, an ARR software loan. Even with the difficult market environment facing software, we were able to exit Mindbody at par by way of a refinancing with a competitor. That leaves just 1 ARR loan remaining in the portfolio, equal to 76 basis points of fair value, versus total ARR exposure of 214 basis points in the prior quarter. Our small exposure to ARR structures illustrates how we intentionally remained underinvested in a private credit segment where we thought stress might appear. New investment commitments for the quarter came to $204 million, a decline of 36% versus the prior quarter. Deal activity lost momentum because of volatility in the software sector and rising geopolitical tensions. As Armen noted, our deal pipeline started to rebuild toward the end of March and into early April. We take encouragement from the fact that new private credit deals are being priced at wider spreads and structured with stronger lender protections. New debt investments carried a weighted average yield of 9.2%, which is 50 basis points above the December quarter. One new private deal from the second quarter is Jonah Energy, a heavily structured loan to a heavy asset, low obsolescence, or Halo, company. This company is a Denver-based independent oil and gas developer whose producing assets span 6 states; in January, Jonah entered into a purchase agreement to acquire Grit Oil & Gas, an upstream oil and gas operator based in the Eagle Ford Basin in Texas. Although the transaction had initially been envisioned by the asset-backed finance market, Jonah put a priority on speed of execution so it could take advantage of oil price appreciation caused by the conflict in Iran. Consequently, the company moved to direct lending and teamed up with Oaktree to make use of our flexibility and capacity to act quickly. Oaktree funds took part in roughly $200 million, or 1/3, of the first lien term loan backing the acquisition. Pricing on the first lien term loan was SOFR plus 600, with mandatory amortization, attractive excess cash flow sweeps, and multiple maintenance covenants. This transaction demonstrates the strength of Oaktree's broader platform, our deep adviser relationships, the capacity to partner across strategy, and the ability to act opportunistically amid a volatile market environment. Now to our software exposure. Under GIC Industry Group classification, software accounts for 21% of the portfolio at fair value spread across 29 issuers; that figure is down roughly 140 basis points from the prior quarter, mainly because of the Mindbody exit. If we use a wide, cautious way of grouping software and technology together, we figure the exposure comes to roughly 26% of the portfolio, and that includes some holdings in health care technology, interactive media and services. As we laid out on Page 8 of the earnings presentation, we use a 7-factor business resilience framework, and we add operating KPIs and financial metrics on top of that. Every investment gets a score and then lands in a high, medium or low AI risk bucket. Looking at our performing debt portfolio, 2 investments, which make up 2.9% of fair value, fall into the high AI risk category; those companies carry a weighted average LTM EBITDA of about $96 million, and that was broadly unchanged versus the prior quarter. LTVs moved up to high 50%, from low 40% last quarter, which mirrors multiple compression among public market comparables; for issuers sitting in the medium and low AI risk categories, weighted average LTM EBITDA comes to roughly $385 million. LTVs sit at around high 40s to low 50s percentage, and we consider that reasonable even with the recent multiple compression. For a lot of these companies, we view AI as a possible tailwind, with management teams and sponsors actively looking at ways to use the technology to improve margins and make their competitive positioning stronger. If you set aside nonaccruals, the weighted average mark on our software portfolio came to 96% as of March 31, 2026, which is down roughly 310 basis points versus last quarter. Those markdowns mostly mirror the repricing of risk and the related spread widening we've seen across liquid credit. Our private credit software marks lined up with what we saw in the broadly syndicated loan market. In most instances, these markdowns don't point to any worsening in underlying company performance. Now on to our nonaccruals. At quarter end, 10 investments sat on nonaccrual, which equals 2.6% of the total debt portfolio at fair value, a drop of 50 basis points from December 2025 and a drop of 200 basis points from March 2025; in March, we restructured Astra after it came out of Chapter 11 and exited the position soon after quarter end, modestly below our mark. That call came from our preference to reallocate our resources and capital toward better risk-adjusted opportunities. We're also still making headway on Avery, where we've seen more condo sales and more units under escrow. During the quarter, 12 units were sold or placed under contract, against our full year underwriting assumption of 6 unit sales. Avery's March 31 valuation assumes only a portion of the units under contract close, though we're cautiously optimistic that we'll close more units down the road. After quarter end, we sold Dominion and All Web Leads, 2 legacy nonaccrual positions acquired from the prior BDC manager; on Dominion, we got $7 million of cash proceeds against a mark of $5 million as of December 31; for the March quarter, we moved the first out to accrual status, marked the first out to par and wrote up the second out modestly. All Web Leads went to a strategic buyer with an AI-focused value creation angle at a price in line with our March 31 mark. At closing, we got about 20% of the March 31 mark in cash, and the rest of the consideration arrived through a seller note plus equity, which puts us in a position where we could ultimately recover more than that March 31 mark. Dominion and All Web Leads are legacy nonaccrual investments, and they show how patient, disciplined, and active we are when it comes to managing the portfolio. We keep working to generate proceeds from additional nonaccruals and equity positions in a manner that optimizes outcomes for OCSL shareholders. Turning to total portfolio metrics as of March 31, first lien senior secured debt made up 84% of total portfolio investments at fair value, and the weighted average yield on debt investments came in at 9.3%, unchanged quarter-over-quarter. Our portfolio stays well diversified, with the average position accounting for 0.7% of our debt portfolio at fair value, and no single position going above 2% of fair value. The median EBITDA for our portfolio companies stood at roughly $182 million, down slightly from the prior quarter because of exits on large cap deals. Portfolio company weighted average leverage was 5.2x and interest coverage was 2.1x, in line with the last quarter. We stay focused on managing the existing portfolio and resolving challenged credits, while keeping the flexibility to take advantage of new investment opportunities ahead. With that, I'll hand the call to Chris, who will review our financial results.
Thanks, Raghav. During our second fiscal quarter, which wrapped up on March 31, 2026, adjusted total investment income came in at $69.7 million, which was down from $74.5 million in the quarter before. That drop was mostly driven by lower reference rates along with reduced non-recurring income tied to smaller prepayment and exit fees. Net expenses fell 6% versus the previous quarter, largely because Part 1 incentive fees came down due to our total return hurdle. We posted adjusted net investment income of $33.7 million, or $0.38 per share, versus $36.1 million, or $0.41 per share, in the prior quarter. Those results were shaped by lower total investment income, partly offset by reduced interest expense and smaller Part 1 incentive fees. NAV per share came in at $15.69, compared with $16.30 a quarter ago. The factors moving NAV were roughly evenly divided between write-downs and certain nonaccruals, mark-to-market swings in quoted names, and spread widening on private credit marks. OCSL stays disciplined about payment-in-kind income, with PIK making up roughly 5.5% of adjusted total investment income for the quarter; that's lower than 6.3% last quarter thanks to the sale of athenahealth PIK preferred at our mark. Roughly 2/3 of our PIK income comes from investments that were structured at origination with the option to PIK. Our net leverage ratio finished the quarter at 1.04x, versus 1.07x a quarter earlier, while total debt outstanding stood at $1.5 billion. That lower leverage reflects portfolio rotation and asset sales over the period. Our long-term target leverage ratio of 0.9x to 1.25x stays the same, though we plan to run leverage toward the mid- to low end of that range. As of March 31, the weighted average interest rate on debt outstanding was 5.9%, compared with 6.1% in the prior quarter, mainly because of lower reference rates. Unsecured debt made up 64% of total debt at quarter end, an increase over the prior quarter. We have plenty of dry powder for market opportunities, with liquidity of approximately $671 million, including $51 million of cash on hand and $620 million of undrawn capacity under our credit facility, up from $576 million of total liquidity at the end of December. Unfunded commitments, including those tied to the joint ventures, were approximately $250 million. Now to our joint ventures. Combined, the JVs held approximately $521 million of investments across 130 portfolio companies and produced aggregate returns on equity of approximately 10% for the quarter. Leverage at the JVs was 1.9x, up slightly from last quarter; with that, I'll hand the call back to the operator for Q&A.
So when we work out what the dividend implies in terms of return — roughly 8.6% of book — that works out to a spread of about 5% over 3-month base rates. Thinking about how your business model works over the long run, where does that return fit — base rate plus 5% within your cycle? Does that represent a trough in the cycle? Is that a sensible long-term target? Help us get a handle on what the return profile ought to be as a function of the base rate.
This is Raghav. I'll kick things off, and then Chris and Brett can add their thoughts; so as you're surely aware, we're really working with 2 levers. The first one is the unlevered asset yield. Again, likely not a shock to anyone given how much capital has been raised in direct lending, in perpetual BDC vehicles, in particular, I'd say spreads in the market for direct lending probably hit their trough in December at somewhere in the mid- to maybe high 400s. Since that point, we've seen — I wouldn't describe it as a dramatic repricing just yet, but definitely a repricing of risk that's significant enough that regular way direct lending deals, so probably the lowest returning deals that show up in our pipeline. These are first lien deals to private equity sponsors are in the low to mid-50s; so they've definitely improved by 50 to 75 basis points. I'd say more looking forward, if you examine the SOFR curve — thanks to the war in the Middle East and the resulting inflation expectations moving higher — the SOFR curve is probably 50 to 60 basis points above where it hit its trough before the Middle East situation. So that's number 2. Outside of sponsor deals, I'd say we do a blend of, obviously, both sponsor and nonsponsor deals; we do corporate lending as well as asset-backed deals, U.S., Europe. On a blended basis, I'd say that when you combine everything, low 500s for sponsor deals, low 600 to 700 in some of the more interesting lending areas we're seeing, which are less commoditized. Our pipeline sits in the high 500s on a spread basis and just under 600, call it, including OID. So when you put it all together, looking forward, obviously, the portfolio on the ground will churn over time. But looking forward, I'd say that spreads on new deals are far more attractive, at least 100 basis points more attractive than they were even 3 months ago. Second, the SOFR curve is certainly helping on the asset side. And then the third piece is leverage. We made the decision to sell a number of names out of our public book. That has a near-term cost, obviously, as you can imagine, which is you have less income-producing assets, your ROE declines as a result. That's the cost. What that gives us is this: with the private pipeline we have repricing upward, we've got substantial liquidity available to put into it. So from where we sit, this isn't a hypothetical opportunity. And so, as time goes on, I do think it's possible that we'll step up leverage bit by bit if this pipeline opportunity keeps going and, ideally, gets bigger. So on the side of unlevered asset yield, my sense is that it's improving. And then second, in order to fund that pipeline, I do anticipate that leverage will rise gradually, and both of those things ought to be supportive of ROE.
Just one brief follow-up. Since December, there's been plenty of talk regarding markets getting better. The empirical item all of us want to feed into our models is spread widening; yet what stands out is that whenever a company says this, they immediately add that protections and covenants have improved too. Clearly we can't put that into a model. Still, it's also something I'm not sure we entirely grasp. Could you offer a few instances of how deal protections are getting stronger, so we can factor that in?
Sure. I mean, the broad technical picture in the market is that if you look only at the unlisted and perpetual BDC segment, that portion of the asset class truly turned into the marginal dollar that was determining price and risk; that segment brought in $110 billion during 2025. I don't know what the figures will end up being, but they're more likely than not to be negative this year, with net outflows rather than positive. So that's a fairly — it isn't a massive slice of the market, since BDCs overall, both public and private, represent roughly 25% of the private credit market, not massive. Yet from a stock standpoint, they aren't massive. From a flow standpoint, they were extremely large. And we believe that's the single shift pushing both better pricing on new deals and also the noneconomic terms you mentioned. So what improvements are we seeing? First, pick requests on new deals have fallen to — I don't want to claim 0, but let's say nearly 0; so that's simply going — it is disappearing. Second, again, you're correct, hard to observe, but I'm certain you know the idea of adjusted EBITDA, which I'd say back in the Gogo days before 4Q 2025, adjusted EBITDA was becoming increasingly unrealistic compared with what we term cash EBITDA and the actual cash earnings profile of the borrowers. That is now improving once more. So that makes two. Three is LME protection, which is — there has always been a sort of tug of war between borrowers and lenders. I'd say, definitely, borrowers likely held more leverage in 2025 than lenders did. Those are improving as well. And then the fourth item I'd mention is the — I'd say the maintenance covenant is returning, particularly for larger deals, in a meaningful way. But the direction of travel is the correct direction, which is that even in some large cap deals in our pipeline, which we characterize as above $100 million of EBITDA, we are beginning to see the maintenance covenant return. So all of those amount to marginal improvements, but they're all heading the right way.
Appreciate everyone being here for today's session. If anything comes up that you'd like to ask, don't hesitate to get in touch with me or anyone on the team. Enjoy the rest of your day.
Ladies and gentlemen, this concludes today's call. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Oaktree Specialty Lending Corporation transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Oaktree Specialty Lending Corporation earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.